UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.427

Sortiert nach

Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

Clinical cancer research, 2006-10, Vol.12 (20), p.6243s-6249s

COLEMAN, Robert E

2006

Link zum Volltext

Verfügbarkeit prüfen

Bisphosphonates as treatment of bone metastases

Current pharmaceutical design, 2010-04, Vol.16 (11), p.1262

2010

Link zum Volltext

Verfügbarkeit prüfen

Bisphosphonates: Clinical Experience

The oncologist (Dayton, Ohio), 2004-09, Vol.9 (S4), p.14-27

Coleman, Robert E.

2004

Link zum Volltext

Verfügbarkeit prüfen

Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment

Clinical cancer research, 2019-05, Vol.25 (9), p.2769-2782

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1051-1058

2008

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA

The Prostate, 2016-07, Vol.76 (10), p.905-916

2016

Link zum Volltext

Verfügbarkeit prüfen

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial

PLoS medicine, 2019-11, Vol.16 (11), p.e1002960

2019

Link zum Volltext

Verfügbarkeit prüfen

Endocrine aspects of bone metastases

The lancet. Diabetes & endocrinology, 2014-06, Vol.2 (6), p.500-512

2014

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid

Journal of clinical oncology, 2005-08, Vol.23 (22), p.4925-4935

2005

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

Clinical cancer research, 2008-10, Vol.14 (19), p.6336-6342

2008

Link zum Volltext

Verfügbarkeit prüfen

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Link zum Volltext

Verfügbarkeit prüfen

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

The lancet oncology, 2007-02, Vol.8 (2), p.119-127

2007

Link zum Volltext

Verfügbarkeit prüfen

Potential Anticancer Properties of Bisphosphonates

Seminars in oncology, 2010-06, Vol.37, p.S53-S65

2010

Link zum Volltext

Verfügbarkeit prüfen

Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group

Cancer treatment reviews, 2008, Vol.34, p.S3-S18

2008

Link zum Volltext

Verfügbarkeit prüfen

Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04)

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2685-2691

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer

Breast cancer research and treatment, 2010-10, Vol.123 (3), p.767-779

2010

Link zum Volltext

Verfügbarkeit prüfen

Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group

Journal of bone oncology, 2020-12, Vol.25, p.100311-100311, Article 100311

2020

Link zum Volltext

Verfügbarkeit prüfen

Metastasis and bone loss: Advancing treatment and prevention

Cancer treatment reviews, 2010-12, Vol.36 (8), p.615-620

2010

Link zum Volltext

Verfügbarkeit prüfen

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Clinical cancer research, 2008-10, Vol.14 (20), p.6690-6696

2008

Link zum Volltext

Verfügbarkeit prüfen

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

International journal of cancer, 2010-01, Vol.126 (2), p.522-532

2010

Link zum Volltext

Verfügbarkeit prüfen

Current perspectives on bone metastases in castrate-resistant prostate cancer

Cancer and metastasis reviews, 2018-03, Vol.37 (1), p.189-196

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevention and treatment of bone metastases

Nature reviews. Clinical oncology, 2012-02, Vol.9 (2), p.76-78

Coleman, Robert E

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.427

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.265)
Mit Volltextzugriff
(1.228)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.419)
Japanisch
(184)
Norwegisch
(3)
Spanisch
(1)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(57)
The New England Journal Of Medicine
(31)
Cancer
(26)
Clinical Cancer Research
(25)
Bioorganic & Medicinal Chemistry Letters
(22)
Gynecologic Oncology
(22)
Cancer Research
(18)
Seminars In Oncology
(16)
Neurology
(15)
Blood
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

Bisphosphonates as treatment of bone metastases

Bisphosphonates: Clinical Experience

Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

Endocrine aspects of bone metastases

Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

Potential Anticancer Properties of Bisphosphonates

Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study

Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04)

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer

Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group

Metastasis and bone loss: Advancing treatment and prevention

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

Current perspectives on bone metastases in castrate-resistant prostate cancer

Prevention and treatment of bone metastases

Suchergebnisse filtern